Wangjun Liao
Impact in
- Cancer Research top 0.2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- RNA modifications and cancer 19
- Circular RNAs in diseases 15
- Oncology 59
- Cancer Immunotherapy and Biomarkers 20
- Colorectal Cancer Treatments and Studies 11
- Co-authors
- Yulin Liao (126 shared papers)Jianping Bin (110 shared papers)Min Shi (62 shared papers)Rui Zhou (33 shared papers)Dongqiang Zeng (27 shared papers)Na Huang (27 shared papers)Li Sun (20 shared papers)Jingwen Zhang (15 shared papers)
- Journals
- Journal of Clinical Oncology (13 papers)Oncotarget (7 papers)Theranostics (6 papers)Scientific Reports (5 papers)Cell Death and Disease (5 papers)
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Wangjun Liao
217 papers receiving 9.0k citations
Wangjun Liao's Hit Papers
Peers
Comparison fields: 5 of 130
- Cancer Research 2.6k
- Oncology 1.7k
- Pulmonary and Respiratory Medicine 1.9k
- Molecular Biology 4.0k
- Immunology 907
Countries citing papers authored by Wangjun Liao
This map shows the geographic impact of Wangjun Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wangjun Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wangjun Liao more than expected).
Fields of papers citing papers by Wangjun Liao
This network shows the impact of papers produced by Wangjun Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wangjun Liao. The network helps show where Wangjun Liao may publish in the future.
Co-authors
The 25 scholars most cited alongside Wangjun Liao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 222 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | IOBR: Multi-Omics Immuno-Oncology Biological Research to Decode Tumor Microenvironment and Signatures Hit paper breakdown → | 2021 | 796 |
| 2 | Tumor Microenvironment Characterization in Gastric Cancer Identifies Prognostic and Immunotherapeutically Relevant Gene Signatures Hit paper breakdown → | 2019 | 716 |
| 3 | Loss of Super-Enhancer-Regulated circRNA Nfix Induces Cardiac Regeneration After Myocardial Infarction in Adult Mice Hit paper breakdown → | 2019 | 365 |
| 4 | 2019 | 235 | |
| 5 | 2017 | 233 | |
| 6 | 2019 | 204 | |
| 7 | 2018 | 196 | |
| 8 | 2018 | 189 | |
| 9 | 2017 | 167 | |
| 10 | 2021 | 166 | |
| 11 | 2018 | 156 | |
| 12 | 2018 | 153 | |
| 13 | 2015 | 120 | |
| 14 | 2020 | 112 | |
| 15 | 2014 | 110 | |
| 16 | 2020 | 110 | |
| 17 | 2022 | 106 | |
| 18 | 2016 | 104 | |
| 19 | 2020 | 101 | |
| 20 | 2013 | 98 |
About Wangjun Liao
Wangjun Liao is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine, having authored 222 papers that have together received 9.0k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (21 papers), Cancer Immunotherapy and Biomarkers (20 papers), RNA modifications and cancer (19 papers), Circular RNAs in diseases (15 papers), Gastric Cancer Management and Outcomes (13 papers), Colorectal Cancer Treatments and Studies (11 papers), Ferroptosis and cancer prognosis (11 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers). The work is most often cited by research in Cancer Research (2.6k citations), Oncology (1.7k citations), Pulmonary and Respiratory Medicine (1.9k citations), Molecular Biology (4.0k citations) and Immunology (907 citations). Wangjun Liao has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Yulin Liao, Jianping Bin, Min Shi, Rui Zhou, Dongqiang Zeng, Na Huang, Li Sun, Jingwen Zhang, Jinjun Rao and Huiying Sun. Their work appears in journals such as Journal of Clinical Oncology, Oncotarget, Theranostics, Scientific Reports and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.